SARS-CoV-2 dependence on host pathways
- 26 February 2021
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6532), 884-885
- https://doi.org/10.1126/science.abg6837
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host DefensesCell, 2020
- Characteristics of SARS-CoV-2 and COVID-19Nature Reviews Microbiology, 2020
- SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translationNature Structural & Molecular Biology, 2020
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2Science, 2020
- Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in MiceCell Reports, 2020
- Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in micePublished by Cold Spring Harbor Laboratory ,2020
- Transcription and Translation Inhibitors in Cancer TreatmentFrontiers in Chemistry, 2020
- Viral RNA structure-based strategies to manipulate translationNature Reviews Microbiology, 2018
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronavirusesScience Translational Medicine, 2017
- Viral and Cellular mRNA Translation in Coronavirus-Infected CellsAdvances in Virus Research, 2015